Funded Tech Companies
Clade Therapeutics
Clade Therapeutics is a biopharmaceutical growth company, based in Cambridge. VC investment was provided by Bristol-Myers Squibb, Syncona and LifeSci Venture Partners.
Company Overview
Company Name
Clade Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Kendall Sq.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Our platform technology immune cloaks human pluripotent stem cells and their adult derivatives enabling the development of true 'off-the-shelf' cell transplantation therapies. Combined with an unparalleled expertise in generating stem cell-derived adult T, NK and B cells, Clade promises to become a leading innovator in developing widely accessible cell medicines.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/6/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chad Cowan
Chief Operating Officer
Leandro Vetcher
President
James Glasheen
Company Investors
- Bristol-Myers Squibb
- Syncona (Martin Murphy)
- LifeSci Venture Partners (Ryan Cinalli)
- Emerson Collective (Neil White)
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs